Balaxi Pharmaceuticals Statistics

Total Valuation

NSE:BALAXI has a market cap or net worth of INR 2.64 billion. The enterprise value is 2.78 billion.

Market Cap	2.64B
Enterprise Value	2.78B

Important Dates

The last earnings date was Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

NSE:BALAXI has 50.91 million shares outstanding. The number of shares has increased by 7.29% in one year.

Current Share Class	50.91M
Shares Outstanding	50.91M
Shares Change (YoY)	+7.29%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	4.93%
Owned by Institutions (%)	9.33%
Float	8.26M

Valuation Ratios

The trailing PE ratio is 11.44.

PE Ratio	11.44
Forward PE	n/a
PS Ratio	0.90
PB Ratio	1.14
P/TBV Ratio	1.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.48, with an EV/FCF ratio of -4.96.

EV / Earnings	11.11
EV / Sales	0.95
EV / EBITDA	7.48
EV / EBIT	7.88
EV / FCF	-4.96

Financial Position

The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.23.

Current Ratio	4.45
Quick Ratio	2.75
Debt / Equity	0.23
Debt / EBITDA	1.44
Debt / FCF	-0.95
Interest Coverage	12.04

Financial Efficiency

Return on equity (ROE) is 11.58% and return on invested capital (ROIC) is 8.73%.

Return on Equity (ROE)	11.58%
Return on Assets (ROA)	7.76%
Return on Invested Capital (ROIC)	8.73%
Return on Capital Employed (ROCE)	13.81%
Revenue Per Employee	4.88M
Profits Per Employee	417,837
Employee Count	600
Asset Turnover	1.03
Inventory Turnover	2.06

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.45% in the last 52 weeks. The beta is 0.59, so NSE:BALAXI's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-51.45%
50-Day Moving Average	58.35
200-Day Moving Average	77.15
Relative Strength Index (RSI)	41.66
Average Volume (20 Days)	201,951

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:BALAXI had revenue of INR 2.93 billion and earned 250.70 million in profits. Earnings per share was 4.54.

Revenue	2.93B
Gross Profit	1.27B
Operating Income	353.21M
Pretax Income	286.70M
Net Income	250.70M
EBITDA	372.15M
EBIT	353.21M
Earnings Per Share (EPS)	4.54

Full Income Statement

Balance Sheet

The company has 394.00 million in cash and 534.25 million in debt, giving a net cash position of -140.26 million or -2.76 per share.

Cash & Cash Equivalents	394.00M
Total Debt	534.25M
Net Cash	-140.26M
Net Cash Per Share	-2.76
Equity (Book Value)	2.32B
Book Value Per Share	41.85
Working Capital	1.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -350.03 million and capital expenditures -211.19 million, giving a free cash flow of -561.23 million.

Operating Cash Flow	-350.03M
Capital Expenditures	-211.19M
Free Cash Flow	-561.23M
FCF Per Share	-11.02

Full Cash Flow Statement

Margins

Gross margin is 43.36%, with operating and profit margins of 12.07% and 8.57%.

Gross Margin	43.36%
Operating Margin	12.07%
Pretax Margin	9.80%
Profit Margin	8.57%
EBITDA Margin	12.72%
EBIT Margin	12.07%
FCF Margin	n/a

Dividends & Yields

NSE:BALAXI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.29%
Shareholder Yield	n/a
Earnings Yield	9.48%
FCF Yield	-21.22%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 30, 2024. It was a forward split with a ratio of 5.

Last Split Date	May 30, 2024
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a